Skip to main content

Advertisement

SpringerLink
Log in

Histopathology and immunohistochemistry of adrenal medullary tumors and paragangliomas

  • EPS Proceedings
  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

Paragangliomas arise from sympathetic or parasympathetic paraganglia and should now be defined by their site and type. The term pheochromocytoma is reserved for intraadrenal tumors. This short review discusses the gross and microscopic features, the immunohistochemical profile, the problem of recognizing malignant potential, and the rare instances where a differential diagnosis has to be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. DeLellis RA LR, Heitz PU, Eng C. Tumours of endocrine organs. Lyon: IARC Press, 2004.

    Google Scholar 

  2. Baysal BE. Hereditary paraganglioma targets diverse paraganglia. J Med Genet 39: 617–622, 2002.

    Article  PubMed  CAS  Google Scholar 

  3. Ross JH. Pheochromocytoma. Special considerations in children. Urol Clin North Am 27: 393–402, 2000.

    Article  PubMed  CAS  Google Scholar 

  4. Tischler AS. The adrenal medulla and extradrenal paraganglia. In: Kovacs K, Asa SL, eds. Functional endocrine pathology. Malden: Blackwell Science; 1998:550–595.

    Google Scholar 

  5. Lack EE. Tumors of the adrenal gland and extra-adrenal paraganglia. Washington DC: Armed Forces Institute of Pathology, 1997.

    Google Scholar 

  6. Bertherat J, Gimenez-Roqueplo AP. New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas. Horm Metab Res 37: 384–390, 2005.

    Article  PubMed  CAS  Google Scholar 

  7. Bulow B, Ahren B. Adrenal incidentaloma— experience of a standardized diagnostic programme in the Swedish prospective study. J Intern Med 252: 239–246, 2002.

    Article  PubMed  CAS  Google Scholar 

  8. Medeiros LJ, Wolf BC, Balogh K, Federman M. Adrenal pheochromocytoma: a clinicopathologic review of 60 cases. Hum Pathol 16: 580–589, 1985.

    Article  PubMed  CAS  Google Scholar 

  9. Chetty R, Clark SP, Taylor DA. Pigmented pheochromocytomas of the adrenal medulla. Hum Pathol 24: 420–423, 1993.

    Article  PubMed  CAS  Google Scholar 

  10. Linnoila RI, Keiser HR, Steinberg SM, Lack EE. Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases, including unusual histologic features. Hum Pathol 21: 1168–1180, 1990.

    Article  PubMed  CAS  Google Scholar 

  11. Tischler AS. Divergent differentiation in neuroendocrine tumors of the adrenal gland. Semin Diagn Pathol 17: 120–126, 2000.

    PubMed  CAS  Google Scholar 

  12. Ramsay JA, Asa SL, van Nostrand AW, Hassaram ST, de Harven EP. Lipid degeneration in pheochromocytomas mimicking adrenal cortical tumors. Am J Surg Pathol 11: 480–486, 1987.

    Article  PubMed  CAS  Google Scholar 

  13. Li M, Wenig BM. Adrenal oncocytic pheochromocytoma. Am J Surg Pathol 24: 1552–1557, 2000.

    Article  PubMed  CAS  Google Scholar 

  14. Koch CA, Mauro D, Walther MM, et al. Pheochromocytoma in von Hippel-Lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2. Endocr Pathol 13: 17–27, 2002.

    Article  PubMed  CAS  Google Scholar 

  15. Carney JA, Sizemore GW, Sheps SG. Adrenal medullary disease in multiple endocrine neoplasia, type 2: pheochromocytoma and its precursors. Am J Clin Pathol 66: 279–290, 1976.

    PubMed  CAS  Google Scholar 

  16. DeLellis RA, Wolfe HJ, Gagel RF, et al. Adrenal medullary hyperplasia. A morphometric analysis in patients with familial medullary thyroid carcinoma. Am J Pathol 83: 177–196, 1976.

    PubMed  CAS  Google Scholar 

  17. Lack EE, Cubilla AL, Woodruff JM, Lieberman PH. Extra-adrenal paragangliomas of the retroperitoneum: A clinicopathologic study of 12 tumors. Am J Surg Pathol 4: 109–120, 1980.

    PubMed  CAS  Google Scholar 

  18. Sclafani LM, Woodruff JM, Brennan MF. Extraadrenal retroperitoneal paragangliomas: natural history and response to treatment. Surgery 108: 1124–1129; discusion 1129–1130, 1990.

    PubMed  CAS  Google Scholar 

  19. Hayes WS, Davidson AJ, Grimley PM, Hartman DS. Extraadrenal retroperitoneal paraganglioma: clinical, pathologic, and CT findings. AJR Am J Roentgenol 155: 1247–1250, 1990.

    PubMed  CAS  Google Scholar 

  20. Khorram-Manesh A, Ahlman H, Jansson S, Nilsson O. N-cadherin expression in adrenal tumors: upregulation in malignant pheochromocytoma and downregulation in adrenocortical carcinoma. Endocr Pathol 13: 99–110, 2002.

    Article  PubMed  CAS  Google Scholar 

  21. Lloyd RV, Sisson JC, Shapiro B, Verhofstad AAJ. Immunohistochemical localization of epinephrine, norepinephrine, catecholamine-synthesizing enzymes and chromogranin in neuroendocrine cells and tumours. Am J Pathol 125: 45–54, 1986.

    PubMed  CAS  Google Scholar 

  22. Kimura N, Nakazato Y, Nagura H, Sasano N. Expression of intermediate filaments in neuroendocrine tumors. Arch Pathol Lab Med 114: 506–510, 1990.

    PubMed  CAS  Google Scholar 

  23. Chetty R, Pillay P, Jaichand V. Cytokeratin expression in adrenal phaeochromocytomas and extra-adrenal paragangliomas. J Clin Pathol 51: 477–478, 1998.

    Article  PubMed  CAS  Google Scholar 

  24. Lloyd RV, Blaivas M, Wilson BS. Distribution of chromogranin and S-100 protein in normal and abnormal adrenal medullary tissues. Arch Pathol Lab Med 109: 633–635, 1985.

    PubMed  CAS  Google Scholar 

  25. Moreno AM, Castilla-Guerra L, Martinez-Torres MC, Torres-Olivera F, Fernandez E, Galera-Davidson H. Expression of neuropeptides and other neuroendocrine markers in human phaeochromocytomas. Neuropeptides 33: 159–163, 1999.

    Article  PubMed  CAS  Google Scholar 

  26. Alvarez P, Isidro L, Gonzalez-Martin M, Loidi L, Arnal F, Cordido F. Ectopic adrenocorticotropic hormone production by a non-catecholamine secreting pheochromocytoma. J Urol 167: 2514–2515, 2002.

    Article  PubMed  Google Scholar 

  27. van der Harst E, Bruining HA, Jaap Bonjer H, et al. Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases. J Pathol 191: 175–180, 2000.

    Article  PubMed  Google Scholar 

  28. Thompson LD. Pheochromocytoma of the adrenal gland scaled score (PASS) to separate benign from malignant neoplasms: a clinico-pathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 26: 551–566, 2002.

    Article  PubMed  Google Scholar 

  29. Linnoila RI, Lack EE, Steinberg SM, Keiser HR. Decreased expression of neuropeptides in malignant paragangliomas: an immunohistochemical study. Hum Pathol 19: 41–50, 1988.

    Article  PubMed  CAS  Google Scholar 

  30. Grouzmann E, Gicquel G, Plouin PF, Schlumberger M, Comoy E, Bohoun C. Neuropeptide Y and neuron-specific enolase levels in benign and malignant pheochromocytomas. Cancer 66: 1833–1835, 1990.

    Article  PubMed  CAS  Google Scholar 

  31. Achilles EA, Padberg GC, Holl K, Klöppel G, Schröder S. Immunocytochemistry of paragangliomas—value of staiing for S-100 protein and glial fibrillary acidic protein in diagnosis and prognosis. Histopathology 18: 453–458, 1991.

    Article  PubMed  CAS  Google Scholar 

  32. Unger P, Hoffman K, Pertsemlidis D, Thung S, Wolfe D, Kaneko M. S100 protein-positive sustentacular cells in malignant and locally aggressive adrenal pheochromocytomas. Arch Pathol Lab Med 115: 484–487, 1991.

    PubMed  CAS  Google Scholar 

  33. Kimura N, Watanabe T, Noshiro T, Shizawa S, Miura Y. Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors. Endocr Pathol 16: 23–32, 2005.

    Article  PubMed  Google Scholar 

  34. August C, August K, Schroeder S, et al. CGH and CD 44/MIB-1 immunohistochemistry are helpful to distinguish metastasized from nonmetastasized sporadic pheochromocytomas. Mod Pathol 17: 1119–1128, 2004.

    Article  PubMed  CAS  Google Scholar 

  35. Kumaki N, Kajiwara H, Kameyama K, et al. Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical and paragangliomas using immunohistochemical techniques. Endocr Pathol 13: 149–156, 2002.

    Article  PubMed  Google Scholar 

  36. Nagura S, Katoh R, Kawaoi A, Kobayashi M, Obara T, Omata K. Immunohistochemical estimations of growth activity to predict biological behavior of pheochromocytomas. Mod Pathol 12: 1107–1111, 1999.

    PubMed  CAS  Google Scholar 

  37. Clarke MR, Weyant RJ, Watson CG, Carty SE. Prognostic markers in pheochromocytoma. Hum Pathol 29: 522–526, 1998.

    Article  PubMed  CAS  Google Scholar 

  38. Eisenhofer G, Bornstein SR, Brouwers FM, et al. Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer 11: 423–436, 2004.

    Article  PubMed  CAS  Google Scholar 

  39. Portel-Gomes GM, Grimelius L, Johansson H, Wilander E, Stridsberg M. Chromogranin A in human neuroendocrine tumors: an immunohistochemical study with region-specific antibodies. Am J Surg Pathol 25: 1261–1267, 2001.

    Article  PubMed  CAS  Google Scholar 

  40. Beltrami CA, Barbatelli G, Criante P, Paliaga A, Amadi CE. An immunohistochemical study in thyroid cancer. Appl Pathol 5: 229–245, 1987.

    PubMed  CAS  Google Scholar 

  41. Katoh R, Miyagi E, Nakamura N, et al. Expression of thyroid transcription factor-1 (TTF-1) in human C cells and medullary thyroid carcinomas. Hum Pathol 31: 386–393, 2000.

    Article  PubMed  CAS  Google Scholar 

  42. Fonseca E, Nesland JM, Hoie J, Sobrinho-Simoes M. Pattern of expression of intermediate cytokeratin filaments in the thyroid gland: an immunohistochemical study of simple and stratified epithelial-type cytokeratins. Virchows Arch 430: 239–245, 1997.

    Article  PubMed  CAS  Google Scholar 

  43. Haak HR, Fleuren GJ. Neuroendocrine differentiation of adrenocortical tumors. Cancer 75: 860–864, 1995.

    Article  PubMed  CAS  Google Scholar 

  44. Munro LM, Kennedy A, McNicol AM. The expression of inhibin/activin subunits in the human adrenal cortex and its tumours. J Endocrinol 161: 341–347, 1999.

    Article  PubMed  CAS  Google Scholar 

  45. Renshaw AA, Granter SR. A comparison of A103 and inhibin reactivity in adrenal cortical tumors: distinction from hepatocellular carcinoma and renal tumors. Mod Pathol 11: 1160–1164, 1998.

    PubMed  CAS  Google Scholar 

  46. Busam KJ, Iversen K, Coplan KA, et al. Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors. Am J Surg Pathol 22: 57–63, 1998.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Anne Marie McNicol MD, FRCPATH

    Present address: Reader in Pathology, University of Glasgow, Pathology Department, Royal Infirmary, Glasgow Scotland, UK

Authors and Affiliations

    Authors
    1. Anne Marie McNicol MD, FRCPATH
      View author publications

      You can also search for this author in PubMed Google Scholar

    Rights and permissions

    Reprints and permissions

    About this article

    Cite this article

    McNicol, A.M. Histopathology and immunohistochemistry of adrenal medullary tumors and paragangliomas. Endocr Pathol 17, 329–336 (2006). https://doi.org/10.1007/s12022-006-0004-2

    Download citation

    • Issue Date:

    • DOI: https://doi.org/10.1007/s12022-006-0004-2

    Key Words

    Search

    Navigation